Folvite and Decadron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Folvite (folic acid) and Decadron (dexamethasone). Common drug interactions include abdominal pain upper among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Folvite and Decadron. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Folvite?

Folvite has active ingredients of folic acid. eHealthMe is studying from 2,529 Folvite users. Check the latest studies of Folvite.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.



On Jul, 16, 2026

65 people who take Folvite and Decadron together, and have interactions are studied.

Folvite and Decadron drug interactions.

What are the common drug interactions of Folvite and Decadron, by gender? *:

female:

  1. Abdominal pain upper
  2. Diarrhoea
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Decreased appetite
  5. Drug hypersensitivity
  6. Pneumonia
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Dizziness
  9. Leukopenia (less number of white blood cells in blood)
  10. Pericardial effusion (fluid around the heart)

male:

  1. Death
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Fatigue (feeling of tiredness)
  4. Glomerular filtration rate decreased
  5. Renal failure (kidney dysfunction)
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Anaemia (lack of blood)
  8. Decreased appetite
  9. Failure to thrive (inadequate weight gain and physical growth in children)
  10. Malignant neoplasm progression (cancer tumour came back)

What are the common drug interactions of Folvite and Decadron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Alanine aminotransferase increased
  2. Anaemia (lack of blood)
  3. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  4. Aspartate aminotransferase increased
  5. Blood lactate dehydrogenase increased
  6. Dizziness
  7. Drug intolerance (drug sensitivity)
  8. Dyspnoea exertional (breathlessness or shortness of breath)
  9. Fatigue (feeling of tiredness)
  10. Headache (pain in head)

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Gallbladder disorder

40-49:

  1. Scrotal ulcer
  2. Abdominal pain
  3. Abnormal dreams
  4. Anxiety
  5. Asthenia (weakness)
  6. Chest pain
  7. Constipation
  8. Depression
  9. Dizziness postural
  10. Drug hypersensitivity

50-59:

  1. Blood immunoglobulin m increased
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Death
  4. Diabetes mellitus inadequate control
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Encephalopathy (functioning of the brain is affected by some agent or condition)
  7. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  8. Fatigue (feeling of tiredness)
  9. Gastroenteritis (inflammation of stomach and intestine)
  10. Haematuria (presence of blood in urine)

60+:

  1. Fatigue (feeling of tiredness)
  2. Glomerular filtration rate decreased
  3. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  4. Family stress
  5. Haematocrit decreased
  6. Hypertension (high blood pressure)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Hypokalaemia (low potassium)
  9. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  10. Lymphocyte percentage increased

What are the existing conditions these people have? *

  1. Pain: 24 people, 36.92%
  2. Nausea (feeling of having an urge to vomit): 19 people, 29.23%
  3. Constipation: 14 people, 21.54%
  4. Ovarian Cancer (cancer of ovary): 9 people, 13.85%
  5. Lung Cancer - Non-Small Cell (lung cancer): 7 people, 10.77%
  6. Wheezing (a high-pitched whistling sound made while you breath): 6 people, 9.23%
  7. Stress And Anxiety: 6 people, 9.23%
  8. Dyspnea (difficult or laboured breathing): 6 people, 9.23%
  9. Lung Neoplasm Malignant (cancer tumour of lung): 5 people, 7.69%
  10. High Blood Pressure: 5 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Folvite and Decadron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Folvite and Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Folvite:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Folvite and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Decadron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on folic acid and dexamethasone (the active ingredients of Folvite and Decadron, respectively), and Folvite and Decadron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: